Applied Clinical Trials podkast

ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data

0:00
1:47
Do tyłu o 15 sekund
Do przodu o 15 sekund
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.

Więcej odcinków z kanału "Applied Clinical Trials"